JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> BioPharma Services >> Early Development >> Our Services >> Toxicology Studies

Toxicology studies

Sidebar Image

 

Alternative Toxicology Testing Services

Eurofins BioPharma Product Testing Munich is a leader in the safety testing without animals and deeply committed to the principles of the 3 R´s of Replacement, Reduction and Refinement.

Our evaluation methods incorporate a unique approach that lead to improved prediction of human results.

Our service portfolio includes methods for replacing the use of animals to evaluate acute systemic toxicity, skin and eye irritation and skin allergenicity but also reduce the use of animals for repeated-dose toxicity, carcinogenicity and reproductive toxicity.

Eurofins Munich is in close contact and actively working with independent scientists and regulatory agencies to adopt their methods to satisfy various regulations.

We are pro-active in the development and use of in vitro and ex vivo methods partnering researchers and clients in pre-validation and validation studies.

Eurofins Munich is contributed to the advancement of animal welfare and to inspire others to include human concern for animals as a core aspect of corporate social responsibility.

Our Study Types for Screening and Regulatory purpose include:

  • in silico Safety Modelling
  • Eye Irritancy
  • Skin Corrosivity
  • Skin Sensitization
  • Systemic Toxicity
  • Reproductive Toxicity/Endocrine Disruptor Activity
  • Carcinogenicity
  • Toxicokinetics – Barrier Systems
  • Toxicokinetics – Metabolism
  • Local Tolerance
  • Performance Testing
  • Mechanistic Investigations

 

in vivo Toxicology

In the field of in vivo toxicology and pharmacology testing Eurofins works in close cooperation with two affiliate contract research organizations, Product Safety Labs and BSL BIOSERVICE.

For over 40 years Product Safety Labs (PSL) has been an industry leader in the conduct of acute, subchronic and chronic toxicity studies using various routes of administrations in different species. PSL prides itself on its commitment to quality, offering competitive pricing and on-time reports delivered through its team of expert, professional staff. Among the repeated dose toxicity studies we offer a comprehensive range of Developmental and Reproductive Toxicity testing ( DART), Neurotoxicology, Immunotoxicology, REACH and Endocrine Disruptor services. PSL also offers state-of-the-art capabilities for custom designed studies for  product and discovery development/stewardship.

PSL conducts studies in compliance with Good Laboratory Practices (GLP) for the safety evaluation of Pharmaceuticals, Medical Devices, Food and Dietary Supplements, Agrochemicals and Industrial chemicals following OECD, ICH, U.S. EPA, FDA, EFSA, and JMAFF as well as other global testing guidelines.

BSL BIOSERVICE is an international active contract research organization, located in Munich, Germany. The company offers a broad range of biological safety testing services for (Bio-)Pharmaceuticals, Chemicals, Medical Devices, Agrochemicals, Cosmetics, and Food.

A high degree of customer orientation, high quality and flexibility are core values of BSL's corporate philosophy. A highly experienced team of scientists and regulatory experts guarantees acceptance by national and international authorities and supports customers from early research until finalization of preclinical studies.

BSL BIOSERVICE has been accredited with DIN EN ISO 17025 for biocompatibility testing of medical devices and has been certified in accordance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP). We are listed by the World Health Organization (WHO) and have successfully been audited by the FDA.